Drug-Drug Interactions between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir with or without Dasabuvir

The combination of ombitasvir (an NS5A inhibitor), paritaprevir (an NS3/4A inhibitor) coadministered with ritonavir (r), and dasabuvir (an NS5B nonnucleoside polymerase inhibitor), referred to as the 3D regimen, and the combination of ombitasvir-paritaprevir-r, referred to as the 2D regimen, have de...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: King, Jennifer R., Dutta, Sandeep, Cohen, Daniel, Podsadecki, Thomas J., Ding, Bifeng, Awni, Walid M., Menon, Rajeev M.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2016
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750706/
https://ncbi.nlm.nih.gov/pubmed/26596948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01913-15
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы